A multicenter, phase Ib/2 study of varlitinib plus gemcitabine and cisplatin (gem/cis) for treatment of na&#239;ve, advanced, or metastatic biliary tract cancer (BTC).

varlitinib (ASLAN001) - ASLAN

cisplatin - generics

gemcitabine - generics

https://meetinglibrary.asco.org/record/168656

Do-Youn Oh; Wei-Peng Yong; Li-Tzong Chen; Ji-Won Kim; Alex Yuang-Chi Chang; Jin Hyun Park; Chih-Yi Hsieh; Hsuan-Jen Shih; Nicola McIntyre; Ying-Chen Chen; Wei-Ling Chang; Mark McHale; Bertil Lindmark

Jan 15, 2019